Management of CHF Exacerbation in ESRD Patients

Introduction to ESRD and CHF Management

The National Kidney Foundation's K/DOQI guidelines note that in most dialysis patients, diuretics are ineffective and not indicated for removing excess volume 1

Many ESRD patients retain some residual renal function and can produce 200-500 mL of urine daily, making them potentially responsive to diuretics 1
The American Journal of Kidney Diseases recommends measuring 24-hour urine output or placing a Foley catheter to quantify output, as some patients may still respond to high-dose loop diuretics even in advanced CKD 1

Urgent dialysis or ultrafiltration is required for volume removal in anuric patients, as it is the only effective method to remove fluid 1
Continuation of carvedilol, if already prescribed, improves LV function, decreases hospitalization, and reduces cardiovascular deaths in dialysis patients with dilated cardiomyopathy 1
Continuation of ACE inhibitors despite ESRD is recommended, though dosing must be individualized around dialysis sessions to avoid intradialytic hypotension 1
Avoidance of spironolactone is recommended due to severe hyperkalemia risk in dialysis patients 1

Assessing actual urine output before declaring futility of diuretics is crucial, and a trial of high-dose IV furosemide may be reasonable if the patient is producing >200-400 mL/day 1
If truly anuric (<100 mL/day), proceeding directly to dialysis/ultrafiltration is recommended 1